American Heart Journal

1

Information for Readers

Journal:

Year:

2012

Language:

english

File:

PDF, 112 KB

english, 2012

3

Editorial Board

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 127 KB

english, 2012

4

Presenting symptoms of myocardial infarction predict short- and long-term mortality: The MONICA/KORA Myocardial Infarction Registry

Inge Kirchberger, Margit Heier, Bernhard Kuch, Wolfgang von Scheidt, Christa Meisinger

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 183 KB

english, 2012

5

Cardiovascular effects of 1 year of progressive endurance exercise training in patients with heart failure with preserved ejection fraction

Naoki Fujimoto, Anand Prasad, Jeffrey L. Hastings, Paul S. Bhella, Shigeki Shibata, Dean Palmer, Benjamin D. Levine

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 472 KB

english, 2012

6

Letter to the Editor concerning article “Design of the Trial to Assess Chelation Therapy (TACT)”

Edzard Ernst

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 49 KB

english, 2012

7

Reply to letter to the editor by Edzard Ernst

Gervasio A. Lamas

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 41 KB

english, 2012

8

Risk stratification in acute heart failure: Rationale and design of the STRATIFY and DECIDE studies

Sean P. Collins, Christopher J. Lindsell, Cathy A. Jenkins, Frank E. Harrell, Gregory J. Fermann, Karen F. Miller, Sue N. Roll, Matthew I. Sperling, David J. Maron, Allen J. Naftilan, John A. McPherso

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 575 KB

english, 2012

9

A call to standardize symptom presentation in acute coronary syndromes

John G. Canto, Robert J. Goldberg, George Sopko

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 123 KB

english, 2012

10

Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: An analysis from Diuretic Optimization Strategies in Acute Heart Failure

Ravi V. Shah, Steven McNulty, Christopher M. O'Connor, G. Michael Felker, Eugene Braunwald, Michael M. Givertz

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 252 KB

english, 2012

11

A qualitative systematic review of influences on attendance at cardiac rehabilitation programs after referral

Alexander M. Clark, Kathryn M. King-Shier, David R. Thompson, Melisa A. Spaling, Amanda S. Duncan, James A. Stone, Susan B. Jaglal, Jan E. Angus

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 646 KB

english, 2012

12

The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

Lars Gullestad, Thor Ueland, John Kjekshus, Ståle H. Nymo, Johannes Hulthe, Pieter Muntendam, John J.V. McMurray, John Wikstrand, Pål Aukrust

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 282 KB

english, 2012

13

Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction

Jennifer B. Christian, John K. Finkle, Bonnie Ky, Pamela S. Douglas, David E. Gutstein, Paul D. Hockings, Pierre Lainee, Daniel J. Lenihan, Jay W. Mason, Philip T. Sager, Thomas G. Todaro, Karen A. Hi

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 197 KB

english, 2012

14

Invited editorial commentary for American Heart Journal mechanisms of exercise training in heart failure with preserved ejection fraction: Central disappointment and peripheral promise

Dalane W. Kitzman, Mark J. Haykowsky

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 87 KB

english, 2012

15

Cardiovascular risk assessment: Addition of CKD and race to the Framingham equation

Paul E. Drawz, Sarah Baraniuk, Barry R. Davis, Clinton D. Brown, Pedro J. Colon Sr, Aloysius B. Cujyet, Richard A. Dart, James F. Graumlich, Mario A. Henriquez, Jamaluddin Moloo, Mohammed G. Sakalayen

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 467 KB

english, 2012

16

Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery

Prashant D. Bhave, L. Elizabeth Goldman, Eric Vittinghoff, Judith Maselli, Andrew Auerbach

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 153 KB

english, 2012

17

Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: A propensity score–matched case-control study

Azeem Latib, Francesco Maisano, Letizia Bertoldi, Andrea Giacomini, Joanne Shannon, Micaela Cioni, Alfonso Ielasi, Filippo Figini, Kensuke Tagaki, Annalisa Franco, Remo Daniel Covello, Antonio Grimald

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 500 KB

english, 2012

18

Optimized Duration of Clopidogrel Therapy Following Treatment with the Endeavor Zotarolimus-Eluting Stent in Real-World Clinical Practice (OPTIMIZE) Trial: Rationale and design of a large-scale, randomized, multicenter study

Fausto Feres, Ricardo A. Costa, Deepak L. Bhatt, Martin B. Leon, Roberto V. Botelho, Spencer B. King III, J. Eduardo T. de Paula, José A. Mangione, Décio Salvadori Jr., Marcos O. Gusmão, Hélio Castell

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 316 KB

english, 2012

19

Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: Findings from the EVEREST Trial

Robert J. Mentz, Matthew J. Chung, Mihai Gheorghiade, Peter S. Pang, Mary J. Kwasny, Andrew P. Ambrosy, Muthiah Vaduganathan, Christopher M. O'Connor, Karl Swedberg, Faiez Zannad, Marvin A. Konstam, A

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 511 KB

english, 2012

20

Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial

Gen-Min Lin, Yi-Hwei Li, Lamin E.S. Jaiteh, Chih-Lu Han

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 63 KB

english, 2012

21

Blocking the terminal complement complex: Mismatch and misconception

Pierre Theroux, Catherine Martel, Arnaud Bonnefoy

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 57 KB

english, 2012

22

Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: A double-blind randomized controlled feasibility study

Martin Stout, Garry A. Tew, Helen Doll, Irena Zwierska, Nicola Woodroofe, Kevin S. Channer, John M. Saxton

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 337 KB

english, 2012

23

Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease

Hector Tamez, Carmine Zoccali, David Packham, Julia Wenger, Ishir Bhan, Evan Appelbaum, Yili Pritchett, Yuchiao Chang, Rajiv Agarwal, Christoph Wanner, Donald Lloyd-Jones, Jorge Cannata, B. Taylor Tho

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 482 KB

english, 2012

24

Design and rationale of the Treatment of Acute Coronary Syndromes with Otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non–ST-segment elevation acute coronary syndromes with a planned early invasive strategy

Philippe Gabriel Steg, Shamir R. Mehta, Charles V. Pollack Jr., Christoph Bode, Christophe Gaudin, Karen Fanouillere, Angele Moryusef, Stephen D. Wiviott, Marc S. Sabatine

Journal:

American Heart Journal

Year:

2012

Language:

english

File:

PDF, 398 KB

english, 2012

Volume 164; Issue 6

Table of Contents

Information for Readers

Editorial Board

Presenting symptoms of myocardial infarction predict short- and long-term mortality: The MONICA/KORA Myocardial Infarction Registry

Cardiovascular effects of 1 year of progressive endurance exercise training in patients with heart failure with preserved ejection fraction

Letter to the Editor concerning article “Design of the Trial to Assess Chelation Therapy (TACT)”

Reply to letter to the editor by Edzard Ernst

Risk stratification in acute heart failure: Rationale and design of the STRATIFY and DECIDE studies

A call to standardize symptom presentation in acute coronary syndromes

Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: An analysis from Diuretic Optimization Strategies in Acute Heart Failure

A qualitative systematic review of influences on attendance at cardiac rehabilitation programs after referral

The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction

Invited editorial commentary for American Heart Journal mechanisms of exercise training in heart failure with preserved ejection fraction: Central disappointment and peripheral promise

Cardiovascular risk assessment: Addition of CKD and race to the Framingham equation

Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery

Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: A propensity score–matched case-control study

Optimized Duration of Clopidogrel Therapy Following Treatment with the Endeavor Zotarolimus-Eluting Stent in Real-World Clinical Practice (OPTIMIZE) Trial: Rationale and design of a large-scale, randomized, multicenter study

Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: Findings from the EVEREST Trial

Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial

Blocking the terminal complement complex: Mismatch and misconception

Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: A double-blind randomized controlled feasibility study

Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease

Design and rationale of the Treatment of Acute Coronary Syndromes with Otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non–ST-segment elevation acute coronary syndromes with a planned early invasive strategy